p53-independent role of MDM2 in TGF-beta1 resistance - PubMed (original) (raw)
p53-independent role of MDM2 in TGF-beta1 resistance
P Sun et al. Science. 1998.
Abstract
Transforming growth factor-beta (TGF-beta) inhibits cell proliferation, and acquisition of TGF-beta resistance has been linked to tumorigenesis. A genetic screen was performed to identify complementary DNAs that abrogated TGF-beta sensitivity in mink lung epithelial cells. Ectopic expression of murine double minute 2 rescued TGF-beta-induced growth arrest in a p53-independent manner by interference with retinoblastoma susceptibility gene product (Rb)/E2F function. In human breast tumor cells, increased MDM2 expression levels correlated with TGF-beta resistance. Thus, MDM2 may confer TGF-beta resistance in a subset of tumors and may promote tumorigenesis by interference with two independent tumor suppressors, p53 and Rb.
Similar articles
- RB regulates the stability and the apoptotic function of p53 via MDM2.
Hsieh JK, Chan FS, O'Connor DJ, Mittnacht S, Zhong S, Lu X. Hsieh JK, et al. Mol Cell. 1999 Feb;3(2):181-93. doi: 10.1016/s1097-2765(00)80309-3. Mol Cell. 1999. PMID: 10078201 - E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM, Hu PP, Shen X, Yu Y, Wang XF. Li JM, et al. Proc Natl Acad Sci U S A. 1997 May 13;94(10):4948-53. doi: 10.1073/pnas.94.10.4948. Proc Natl Acad Sci U S A. 1997. PMID: 9144170 Free PMC article. - A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
Woitach JT, Zhang M, Niu CH, Thorgeirsson SS. Woitach JT, et al. Nat Genet. 1998 Aug;19(4):371-4. doi: 10.1038/1258. Nat Genet. 1998. PMID: 9697699 - Regulation of transcription by E2F1/DP1.
Martin K, Trouche D, Hagemeier C, Kouzarides T. Martin K, et al. J Cell Sci Suppl. 1995;19:91-4. doi: 10.1242/jcs.1995.supplement_19.13. J Cell Sci Suppl. 1995. PMID: 8655653 Review. - Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK, Hamel PA. Sidle A, et al. Crit Rev Biochem Mol Biol. 1996 Jun;31(3):237-71. doi: 10.3109/10409239609106585. Crit Rev Biochem Mol Biol. 1996. PMID: 8817077 Review.
Cited by
- The CMG helicase and cancer: a tumor "engine" and weakness with missing mutations.
Xiang S, Reed DR, Alexandrow MG. Xiang S, et al. Oncogene. 2023 Feb;42(7):473-490. doi: 10.1038/s41388-022-02572-8. Epub 2022 Dec 15. Oncogene. 2023. PMID: 36522488 Free PMC article. Review. - Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer.
Sakai H, Kawakami H, Teramura T, Onodera Y, Somers E, Furuuchi K, Uenaka T, Kato R, Nakagawa K. Sakai H, et al. Clin Transl Med. 2021 Jun;11(6):e454. doi: 10.1002/ctm2.454. Clin Transl Med. 2021. PMID: 34185411 Free PMC article. - Targeting MDM2 for novel molecular therapy: Beyond oncology.
Wang W, Qin JJ, Rajaei M, Li X, Yu X, Hunt C, Zhang R. Wang W, et al. Med Res Rev. 2020 May;40(3):856-880. doi: 10.1002/med.21637. Epub 2019 Oct 6. Med Res Rev. 2020. PMID: 31587329 Free PMC article. Review. - CHD1L promotes cell cycle progression and cell motility by up-regulating MDM2 in breast cancer.
Wang W, Wu J, Fei X, Chen W, Li Y, Shen K, Zhu L. Wang W, et al. Am J Transl Res. 2019 Mar 15;11(3):1581-1592. eCollection 2019. Am J Transl Res. 2019. PMID: 30972184 Free PMC article. - Anti-Müllerian Hormone Expression in Endometrial Cancer Tissue.
Gowkielewicz M, Lipka A, Piotrowska A, Szadurska-Noga M, Nowakowski JJ, Dzięgiel P, Majewski MK, Jozwik M, Majewska M. Gowkielewicz M, et al. Int J Mol Sci. 2019 Mar 15;20(6):1325. doi: 10.3390/ijms20061325. Int J Mol Sci. 2019. PMID: 30884769 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous